&lsquo;Les liaisons dangereuses&rsquo;: Hepatitis C, Rituximab and B-cell non-Hodgkin&rsquo;s lymphomas

doi:10.4292/wjgpt.v3.i2.21

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 3, Issue 2

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2827)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-4) series.

Item

Count

PDF

263

HTML

2331

Tables (1-4)

233

Sum=2827

Apr 6, 2012 (publication date) through Oct 2, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Pharmacology and Therapeutics

ISSN

2150-5349

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastrointest Pharmacol Ther. Apr 6, 2012; 3(2): 21-28
Published online Apr 6, 2012. doi: 10.4292/wjgpt.v3.i2.21

Table 1 Clinical significance of commonly performed biochemical liver tests

Liver test	Clinical significance
AST, ALT	Cytolysis
Total bilirubin, γGT, ALP	Cholestasis
Prothrombin time/INR, Albumin, pCHE	Synthesis
Decreased platelet number	Portal hypertension

AST: Aspartate-aminotransferase; ALT: Alanine aminotransferase; γGT: γ-glutamyl transpeptidase; ALP: Alkaline phosphatase; INR: International normalized ratio; pCHE: Pseudo-cholinesterase.

Citation: Marignani M, Fonzo MD, Begini P, Gigante E, Deli I, Pellicelli AM, Gallina S, Santis E, Fave GD, Cox MC. ‘Les liaisons dangereuses’: Hepatitis C, Rituximab and B-cell non-Hodgkin’s lymphomas. World J Gastrointest Pharmacol Ther 2012; 3(2): 21-28
URL: https://www.wjgnet.com/2150-5349/full/v3/i2/21.htm
DOI: https://dx.doi.org/10.4292/wjgpt.v3.i2.21